# ANK2

## Relevance tier by entity

|Entity|Tier|Description                            |
|:------:|:----:|---------------------------------------|
|MCL   |2   |relevance in MCL not firmly established|

## Mutation incidence in large patient cohorts (GAMBL reanalysis)

|Entity|source       |frequency (%)|
|:------:|:-------------:|:-------------:|
|MCL   |GAMBL genomes|1.9          |

## Mutation pattern and selective pressure estimates

|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
|BL    |No  |No                   |1.169           |1.1             |
|DLBCL |No  |No                   |0.393           |0.0             |
|FL    |No  |No                   |0.340           |0.0             |


> [!NOTE]
> First described in MCL in 2014 by [Zhang J](https://pubmed.ncbi.nlm.nih.gov/24682267)


View coding variants in ProteinPaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/ANK2_protein.html)  or [hg38](https://morinlab.github.io/LLMPP/GAMBL/ANK2_protein_hg38.html)

![image](images/proteinpaint/ANK2_NM_001148.svg)

View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/ANK2.html)  or [hg38](https://morinlab.github.io/LLMPP/GAMBL/ANK2_hg38.html)

![image](images/proteinpaint/ANK2.svg)
## ANK2 Expression
![image](images/gene_expression/ANK2_by_pathology.svg)
